-
Product Insights
Epidermolysis Bullosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa – Drugs In Development, 2022, provides an overview of the Epidermolysis Bullosa (Dermatology) pipeline landscape. Epidermolysis bullosa (EB) is a group of inherited bullous disorders characterized by blister formation in response to mechanical trauma. Symptoms include blistering of skin, deformity or loss of fingernails and toenails, internal blistering, including on the throat, esophagus, upper airway, stomach, intestines and urinary tract, skin thickening on palms and soles of the...
-
Product Insights
Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Clostridioides difficile Infections – Drugs In Development, 2022, provides an overview of the Clostridioides difficile Infections (Infectious Disease) pipeline landscape. Clostridium difficile infections are caused by Clostridium difficile, often called C. difficile or C. diff, a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. Symptoms of C. diff infection includes watery diarrhea, with abdominal pain or tenderness, loss of appetite, fever, blood or pus...
-
Product Insights
Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis – Drugs In Development, 2022, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape. Cystic fibrosis (CF) is an inherited disease that causes mucus to build up and clog some of the body’s organs, particularly the lungs and pancreas. Cystic fibrosis affects the cells that produce mucus, sweat and digestive juices. Symptoms include wheezing, breathlessness, repeated lung infections, inflamed nasal passages or a stuffy nose and severe...
-
Product Insights
Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin, the folds of the buttocks, between the breasts, toes, or fingers, and in the navel. Treatment includes anti-fungal drugs. The Candidiasis - drugs...
-
Product Insights
Onychomycosis (Tinea Unguium) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Onychomycosis (Tinea Unguium) pipeline research report provides comprehensive information on the therapeutics under development for Onychomycosis (Tinea Unguium), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features...
-
Sector Analysis
Impact of Mexico on the Pharmaceutical Industry – Thematic Research
The Mexico pharmaceutical market was valued at $21.48 billion in 2020. Mexico has a large and rising middle-class population, a favorable environment for private sector investment, a rise in demand for healthcare services, and relatively high drug prices. The growth of the Mexican pharmaceutical market can be attributed to the large and growing middle-class population, the favorable environment for private sector investment, a rise in demand for healthcare services and pharmaceutical products, and increased quality certifications. Low-cost manufacturing of pharmaceuticals...
-
Product Insights
Atopic Dermatitis (Atopic Eczema) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Atopic Dermatitis is an itchy inflammation of skin. Signs and symptoms of Atopic Dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from scratching. Risk factors include family history of eczema, allergies, hay fever or asthma and gender. The Atopic Dermatitis - Drugs In Development research report provides a comprehensive overview on the...
-
Thematic Analysis
Impact of India on the Pharmaceutical Industry – Thematic Research
The Indian pharmaceutical market was valued at $20.0 billion in 2019 which has increased at a CAGR of more than 6% during the forecast period 2020-2025. In 2020, India was ranked third globally for drug production by volume and 14th by value. The growth of the Indian pharmaceutical market is attributed to innovation in R&D, increased pharmaceutical export, infrastructure development, drug manufacturing, and strong domestic demand. India has the third largest pharma market in the world by volume, after the...
-
Sector Analysis
The Cards and Payments Industry in Czech Republic: Emerging trends and opportunities to 2020
GlobalData’s "The Cards and Payments Industry in Czech Republic: Emerging trends and opportunities to 2020", report provides detailed analysis of market trends in the Czech Republic's cards and payments industry. It provides values and volumes for a number of key performance indicators in the industry, including credit transfers, cheques, cash, payment cards and direct debit during the review period (2012-2016). The report also analyzes various payment card markets operating in the industry, and provides detailed information on the number of...
-
Sector Analysis
Global LNG Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
Global LNG Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals is a comprehensive report on the global LNG industry. The report provides key asset details of all active and planned, LNG liquefaction and regasification terminals in the world by region and country. Information by terminal includes terminal name, operator name and design LNG processing capacity (liquefaction / regasification) for the period 2011–2021. Planned (new build) LNG terminals capacity additions and...